Compare INO & AGPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INO | AGPU |
|---|---|---|
| Founded | 1979 | 2002 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.5M | 77.0M |
| IPO Year | 1999 | N/A |
| Metric | INO | AGPU |
|---|---|---|
| Price | $1.10 | $7.58 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.75 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 271.2K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $42,220,086.00 | N/A |
| Revenue This Year | $20,156.19 | $12,476.23 |
| Revenue Next Year | $421.95 | $55.17 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.37 | N/A |
| 52 Week Low | $1.03 | $1.03 |
| 52 Week High | $2.86 | $10.86 |
| Indicator | INO | AGPU |
|---|---|---|
| Relative Strength Index (RSI) | 43.35 | 57.89 |
| Support Level | $1.03 | $4.54 |
| Resistance Level | $1.23 | $8.81 |
| Average True Range (ATR) | 0.05 | 0.74 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 45.00 | 84.76 |
Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.
Axe Compute Inc functions as an active infrastructure operator. The company intends to expand access to AI compute resources by utilizing the Aethir network, which provides scalable, cost-efficient cloud GPU services for AI, machine learning, gaming, and rendering applications. Through the use of Aethir's decentralized international infrastructure, the company aims to provide access to bare-metal GPUs at scale for both emerging and established organizations.